---
title: 'Daily AI-Based Treatment Adaptation under Weekly Offline MR Guidance in Chemoradiotherapy
  for Cervical Cancer 1: The AIM-C1 Trial'
date: '2024-02-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38398270/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240224170845&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: '(1) Background: External beam radiotherapy (EBRT) and concurrent chemotherapy,
  followed by brachytherapy (BT), offer a standard of care for patients with locally
  advanced cervical carcinoma. Conventionally, large safety margins are required to
  compensate for organ movement, potentially increasing toxicity. Lately, daily high-quality
  cone beam CT (CBCT)-guided adaptive radiotherapy, aided by artificial intelligence
  (AI), became clinically available. Thus, online treatment plans can be adapted ...'
disable_comments: true
---
(1) Background: External beam radiotherapy (EBRT) and concurrent chemotherapy, followed by brachytherapy (BT), offer a standard of care for patients with locally advanced cervical carcinoma. Conventionally, large safety margins are required to compensate for organ movement, potentially increasing toxicity. Lately, daily high-quality cone beam CT (CBCT)-guided adaptive radiotherapy, aided by artificial intelligence (AI), became clinically available. Thus, online treatment plans can be adapted ...